217 related articles for article (PubMed ID: 8750979)
1. [Tardive dyskinesia: an increased risk of neuroleptics in elderly women].
Jessurun AY; Stek ML
Tijdschr Gerontol Geriatr; 1995 Oct; 26(5):197-9. PubMed ID: 8750979
[TBL] [Abstract][Full Text] [Related]
2. Tardive dyskinesia and depressive illness.
Davis KL; Berger PA; Hollister LE
Psychopharmacol Commun; 1976; 2(2):125-30. PubMed ID: 10603
[TBL] [Abstract][Full Text] [Related]
3. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
Bishnoi M; Kumar A; Chopra K; Kulkarni SK
Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
[TBL] [Abstract][Full Text] [Related]
4. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
[TBL] [Abstract][Full Text] [Related]
5. Clinical and neuropathological abnormalities in baboons treated with HPTP, the tetrahydropyridine analog of haloperidol.
Halliday GM; Pond SM; Cartwright H; McRitchie DA; Castagnoli N; Van der Schyf CJ
Exp Neurol; 1999 Jul; 158(1):155-63. PubMed ID: 10448427
[TBL] [Abstract][Full Text] [Related]
6. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
[TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia: relationship with a primary affective disorder.
Rosenbaum AH; Niven RG; Hanson NP; Swanson DW
Dis Nerv Syst; 1977 Jun; 38(6):423-7. PubMed ID: 16734
[TBL] [Abstract][Full Text] [Related]
8. Legal aspects of tardive dyskinesia.
Davis JM; Comaty J
Encephale; 1988 Sep; 14 Spec No():257-61. PubMed ID: 2905653
[TBL] [Abstract][Full Text] [Related]
9. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
[TBL] [Abstract][Full Text] [Related]
10. Narcolepsy, paranoid psychosis, major depression, and tardive dyskinesia.
Schrader G; Hicks EP
J Nerv Ment Dis; 1984 Jul; 172(7):439-41. PubMed ID: 6144722
[TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
Kane JM
J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
[TBL] [Abstract][Full Text] [Related]
12. Patterns of psychotropic drug use and tardive dyskinesia.
Branchey M; Branchey L
J Clin Psychopharmacol; 1984 Feb; 4(1):41-5. PubMed ID: 6141189
[TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia: pathophysiology and animal models.
Casey DE
J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with neuroleptics is not dangerous for the patient. The risk of tardive dyskinesia is increased in overdosing].
Wiesel FA
Lakartidningen; 1987 Sep; 84(40):3174-6. PubMed ID: 2890802
[No Abstract] [Full Text] [Related]
15. Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride.
Koch HJ; Szecsey A; Vogel M; Fischer-Barnicol D
Int J Clin Pract; 2003 Mar; 57(2):147-9. PubMed ID: 12661802
[TBL] [Abstract][Full Text] [Related]
16. [Spontaneous dyskinesia in the elderly and tardive dyskinesia of neuroleptics. A survey among 270 patients (author's transl)].
Bourgeois M; Boueilh P; Tignol J
Encephale; 1980; 6(1):37-9. PubMed ID: 6108850
[TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia: eliminated, forgotten, or overshadowed?
Remington G
Curr Opin Psychiatry; 2007 Mar; 20(2):131-7. PubMed ID: 17278910
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
[TBL] [Abstract][Full Text] [Related]
19. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
20. [Utility of quetiapine in tardive dyskinesia].
Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
